PlusFarma

PlusFarma is a Brazilian specialty pharmaceutical company focused on the commercialization and distribution of high-complexity medicines. The company specializes in therapeutic areas such as oncology, hematology, and rare diseases, providing access to innovative treatments within the Brazilian healthcare market. In 2022, PlusFarma was acquired by Eurofarma, one of Latin America's largest pharmaceutical groups, to strengthen its presence in the specialty and hospital segments. The company operates as a strategic partner for international biotech firms looking to enter the Brazilian market through established distribution channels and regulatory expertise. Its business model emphasizes the management of specialty products that require specific handling and distribution requirements.